期刊文献+

多发性骨髓瘤患者MMP-9、MMP-2表达的研究 被引量:8

Studies of matrix metalloproteinase-9 and matrix metalloproteinase-2 expression in multiple myeloma patients
下载PDF
导出
摘要 背景与目的:近年来的研究发现基质金属蛋白酶(MMPs)与骨重建、骨质重吸收和肿瘤浸润转移等过程有关。我们检测了多发性骨髓瘤(MM)患者的MMP-9和MMP-2水平,以探讨其与MM发病的关系和临床意义。方法:用酶联免疫吸附试验(ELISA)检测了30例MM患者单个核细胞培养液的MMP-9水平、24例MM患者骨髓基质细胞(BMSCs)培养液的MMP-2水平和12例对照组MMP-9、MMP-2水平。结果:19/30例进展期MM组的MMP-9表达水平显著高于11/30稳定期MM组和12例对照组(P<0.05);14/24例进展期MM组BMSCs的MMP-2表达水平显著高于10/24例稳定期MM组和对照组(P<0.05),稳定期MM组和对照组的MMP-9、MMP-2水平无显著差别(P>0.05);12例IgG型MM患者的MMP-9和血免疫球蛋白(M蛋白)水平呈正相关(r=0.87,P=0)。rIL-6(终浓度100ng/m l)、rIL-1β(终浓度10ng/m l)并不能显著改变BMSCs分泌的MMP-2,但9例进展期MM组BMSCs与人骨髓瘤细胞系U266细胞(终浓度2×105/mL)混合培养48小时后,MMP-2水平明显增高,显著高于上述进展期和稳定期MM患者和对照组的BMCSs(均为P<0.05)。结论:MMP-9、MMP-2水平升高与MM的病情进展有关;MMP-9可反映MM患者的肿瘤负荷,可能与MM的肿瘤浸润病理过程有关;而这些过程需骨髓瘤细胞和BMSCs相互作用而完成。 Background and purpose: Matrix Metalloproteinase (MMPs) are related to the process of bone rebuilding, bone resorption, tumor invasion and metastasis. We detected the level of MMP-9 and MMP-2 for multiple myeloma (MM) patients and tried to explore the role and clinical implications of these two proteins in MM. Methods: Expression of MMP-9 was detected in the culture fluid of mononuclear cells from 30 patients with MM and MMP-2 in the culture fluid of bone marrow stromal cells (BMSCs) from 24 patients with MM by ELISA. Results: The level of MMP-9 in 19/30 and MMP-2 in 14/24 patients with active MM were significantly higher than both the patients with stable MM (11/30 and 10/ 24) and 12 normal donors( P 〈 0.05), The levels of MMP-9 and MMP-2 in stable MM patients were not different from normal donors(P 〉0.05) Expression level of MMP-9 in 12 patients with the phenotype of secreting IgG was correlated to the level of M protein( r = 0.87, P = 0 〈 0.05). rlL-6 and rIL-1β did not play a role in stimulating MMP-2 secretion of BMSCs. When BMSCs from 9 patients with active MM were co-cultured with U266 cells ( human MM cell lines ), there was a significant increase of MMP-2 in BMSCs (P 〈0.05). Conclusions: The increase of MMPs is associated with disease progression. The level of MMP-9 is correlative to tumor burden and may have a role in the invasion and pathogenesis of MM. The interaction of myeloma cell and BMSCs is essential for the behavior of MM cells.
出处 《中国癌症杂志》 CAS CSCD 2006年第7期578-580,共3页 China Oncology
关键词 多发性骨髓瘤 MMP 骨髓基质细胞 multiple myeloma matrix metalloproteinase bone marrow stromal ceils
  • 相关文献

参考文献9

  • 1Kelly T, Borset M, Abe E, et al. Matrix Metalloproteinases in multiple myeloma [ J ]. Leukemia and Lymphoma, 2000,37 ( 3-4 ) :273-281.
  • 2张蕾,陈世伦,陈文明,刘晋伟.多发性骨髓瘤血管内皮生长因子和白细胞介素-6相互作用的研究[J].中华内科杂志,2005,44(2):85-88. 被引量:11
  • 3Barille S, Akhoundi C, Collette M, et al. Metalloproteinases in multiple myeloma : production of Matrix Metalloproteinases - 9(MMP-9), activation of proMMP-2 ,and induction of MMP-1 in myeloma cell [ J ]. Blood, 1997,90 ( 4 ) : 1649-1655.
  • 4Sfiridaki A, Miyakis S, Tsirakis G, et al. Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone disease [ J ].Clin Chem Lab Med,2005,43( 9 ) :934-938.
  • 5Vacca A, Ribatti D, Presta M,et al. Bone marrow neovascularization, plasma cell angiogenic potential and Matrix Metalloproteinase-2 secrition parallel progression of human multiple myeloma[J]. Blood, 1999,93(9):3064.
  • 6Valchenborgh EV, Croucher PI, Daeve HD, et al. Multifunetional role of Matrix Metalloproteinases in multiple myeloma-A study in the 5T2 MM Mouse Model [ J ]. Am J Pathol, 2004,165 ( 3 ) : 869-878.
  • 7Curran S, Murray GI. Matrix metalloproteinases in tumor invasion and metastasis [ J ]. J Pathol, 1999,189 ( 3 ) :300-308.
  • 8Valckenborgh EV, Bakkus M, Munaut C, et al. Upregulation of metalloproteinase-9 in mrrine 5333 multiple myeloma cells by interaction with bone marrow endothelial cells [ J]. Inter J Cancer,2002,101(6):512-518.
  • 9Menu E,Asosingh K,Riet IV, et al. Myeloma cells(5TMM) and their interactions with the marrow microenvironment [ J ]. Blood Cells, Molecules and Diseases ,2004,33 ( 2 ) : 111-119.

二级参考文献8

  • 1Bellamy WT. Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies.Semin Oneol, 2001, 28: 551-559.
  • 2Dankbar B, Padre T, Leo R, et al. Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell in teractions inmultiple myeloma. Blood, 2000, 95 : 2630-2636.
  • 3Anderson KC. Multiple myeloma. Advances in disease biology:therapeutic implication. Semin Hematol, 2001,38 (2 Suppl 3) : 6-10.
  • 4Gupta D, Treon SP, Shima Y, et al. Adherence of multiple myeloma cells to bone marrow stromal ceils upregulates vascular endothelial growth factor secretion: therapeutic applications. Leukemia, 2001,15 : 1950-1961.
  • 5Bisping G, Leo R, Wenning D, et al. Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma.Blood, 2003, 101: 2775-2783.
  • 6Hideshima T, Akiyama M, Hayashi T, et al. Targeting p38 MAPK inhibits multiple myloma cell growth in the bone marrow milieu.Blood, 2003, 101 : 703-705.
  • 7Hideshima T, Chauhan D, Schlossman R, et al. The role of tumor necrosis factor a in the pathophysiology of human multiple myeloma:therapeutic applications. Oncogene, 2001,20: 4519-4527.
  • 8Lin B, Podar K, Gupta D, et al. The vascular endothelial growth factor receptor tyrosine kinase inhibior PTK787/ZK222584 inhibits growth and migration of multiple myeloma cells in the bone marrow microenvironment. Cancer Res, 2002, 62 : 5019-5026.

共引文献10

同被引文献60

引证文献8

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部